E Crespo1,2, S Gómez3, V Palacios3, J Galvez3, J M Tenías3, I Cano3, R Peñuela3, A Arcas3, R Crespo3. 1. Hospital Mancha-Centro, Avenida de la Constitución s/n, Alcázar de San Juan, Ciudad Real, Spain. ecresporomero@gmail.com. 2. , C/Coscoja nº3, Alcázar de San Juan, CP: 13600, Ciudad Real, Spain. ecresporomero@gmail.com. 3. Hospital Mancha-Centro, Avenida de la Constitución s/n, Alcázar de San Juan, Ciudad Real, Spain.
Abstract
OBJECTIVE: This study sought to evaluate the long-term osteosynthesis results for AO/OTA 31.A1-A2 pertrochanteric fractures treated with the percutaneous compression plate (PCCP). MATERIALS AND METHODS: This investigation was a retrospective observational descriptive study of 335 patients, with a minimum follow-up of 2 years and a maximum follow-up of 8 years (2004-2011). RESULTS: The average post-operative hospital stay was 6.2 days, and the average decrease in haemoglobin levels after the intervention was 2.7 mg/dL, with transfusion required for one-third of the patients. Complications related to the implant were observed in 4.2 % of patients; the most notable complication was cut-out (2.4 % of patients), and 3 cases involved pseudarthrosis with breakage of the implant (0.9 % of patients). CONCLUSIONS: From the results obtained in this study and an analysis of previously published work, we believe that the PCCP may be the implant of choice for AO/OTA 31.A1-A2 fractures.
OBJECTIVE: This study sought to evaluate the long-term osteosynthesis results for AO/OTA 31.A1-A2 pertrochanteric fractures treated with the percutaneous compression plate (PCCP). MATERIALS AND METHODS: This investigation was a retrospective observational descriptive study of 335 patients, with a minimum follow-up of 2 years and a maximum follow-up of 8 years (2004-2011). RESULTS: The average post-operative hospital stay was 6.2 days, and the average decrease in haemoglobin levels after the intervention was 2.7 mg/dL, with transfusion required for one-third of the patients. Complications related to the implant were observed in 4.2 % of patients; the most notable complication was cut-out (2.4 % of patients), and 3 cases involved pseudarthrosis with breakage of the implant (0.9 % of patients). CONCLUSIONS: From the results obtained in this study and an analysis of previously published work, we believe that the PCCP may be the implant of choice for AO/OTA 31.A1-A2 fractures.
Entities:
Keywords:
Hip fractures; Percutaneous compression plate; Pertrochanteric femoral fractures
Authors: Mary L Forte; Beth A Virnig; Lynn E Eberly; Marc F Swiontkowski; Roger Feldman; Mohit Bhandari; Robert L Kane Journal: J Bone Joint Surg Am Date: 2010-05 Impact factor: 5.284